Measurement of IGF-1 and reference ranges

被引：0

作者：

Spilcke-Liss, Elisabeth ^{[1
]}

Friedrich, Nele ^{[1
]}

Wallaschofski, Henri ^{[1
]}

机构：

[1] Ernst Moritz Arndt Univ Greifswald, Klin Innere Med Endokrinol A, D-17487 Greifswald, Germany

来源：

LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE | 2008年 / 32卷 / 01期

关键词：

growth hormone; insulin-like growth factor I (IGF-1); reference range;

D O I：

10.1515/JLM.2008.001

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Insulin-like growth factor I (IGF-1) represents the key marker for the evaluation of growth hormone (GH) status. A large number of determinants, including age, gender, genetic factors, nutrition and disease states, influence IGF-1 serum levels. Accurate normative data are essential to translate patient data into diagnostic meaning or even use IGF-1 levels for adequate monitoring of patients with an over- or underactive GH axis. Even though reference ranges have been developed in large cohorts of healthy subjects, the dependency of these data on a given assay technology argues for assay specific normative data for IGF-1.

引用

页码：11 / 15

页数：5

共 39 条

[1] PLASMA INSULIN-LIKE GROWTH FACTOR-I/SOMATOMEDIN-C IN ACROMEGALY - CORRELATION WITH THE DEGREE OF GROWTH-HORMONE HYPERSECRETION [J].

BARKAN, AL ;

BEITINS, IZ ;

KELCH, RP .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) :69-73

[2] Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: Establishment of reference ranges with emphasis on puberty [J].

Bereket, A ;

Turan, S ;

Omar, A ;

Berber, M .

HORMONE RESEARCH, 2006, 65 (02) :96-105

[3] GROWTH-HORMONE RESISTANCE AND INHIBITION OF SOMATOMEDIN ACTIVITY BY EXCESS OF INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN IN UREMIA [J].

BLUM, WF ;

RANKE, MB ;

KIETZMANN, K ;

TONSHOFF, B ;

MEHLS, O .

PEDIATRIC NEPHROLOGY, 1991, 5 (04) :539-544

[4]

Borofsky ND, 2002, CLIN CHEM, V48, P2248

[5] Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system:: Results from a multicenter study [J].

Brabant, G ;

von zur Mühlen, A ;

Wüster, C ;

Ranke, MB ;

Kratzsch, J ;

Kiess, W ;

Ketelslegers, JM ;

Wilhelmsen, L ;

Hulthén, L ;

Saller, B ;

Mattsson, A ;

Wilde, J ;

Schemer, R ;

Kann, P .

HORMONE RESEARCH, 2003, 60 (02) :53-60

[6] Insulin-like growth factor-I: marker for diagnosis of acromegaly and monitoring the efficacy of treatment [J].

Brabant, G .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 :S15-S20

[7] REGULATION OF MATERNAL IGF-I BY PLACENTAL GH IN NORMAL AND ABNORMAL HUMAN PREGNANCIES [J].

CAUFRIEZ, A ;

FRANKENNE, F ;

HENNEN, G ;

COPINSCHI, G .

AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (04) :E572-E577

[8] Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis [J].

Chen, Jian-Wen ;

Nielsen, Michael F. ;

Caumo, Andrea ;

Vilstrup, Hendrik ;

Christiansen, Jens Sandahl .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 155 (02) :285-292

[9] Overview of the IGF-I system [J].

Cohen, P .

HORMONE RESEARCH, 2006, 65 :3-8

[10]

deBoer H, 1996, INT J OBESITY, V20, P580

← 1 2 3 4 →